The current study was undertaken to evaluate the effects of a locally-produced recombinant porcine somatotropin (pST) on growth perfermance and pork quality of finishing pigs. A total of 32 barrows weighing average 61kg were employed for the 6-week growth trial : 8 barrows were allocated into the control group (CONT): 8 barrows into the slow release-low dose pST group (SR-L); 8 barrows into the solve release - high dose pST group (SR-H); 8 barrows into the daily pST group(DAILY). CONT pigs received no pST. SR-L and SR-H pigs were treated with pST twice during 6 week trial(Each dose contained the pST equavalent to 50 ㎍ and 100 ㎍ per day, respectively). DAILY pigs received 100 ㎍ pST/㎏ B W daily. All pigs were fed a commercial feed containing 0.87% lysine ad lib. There was no significant difference in average daily gain among treatments. Feed/gain was reduced by 20% in DAILY (3.09 vs 3.85; p$lt;0.05) and 11% in SR-H (3.43 vs 3.84; p$lt;0.05) compared to the CONT. Backfat of the DAILY group was 20% thinner than that of the CONT and loin eye area was wider by 17% (p$lt;0.05) in DAILY group, compared to the CONT. The extent of the improvement in growth perfermance of SR groups was less (p$lt;0.05) than that of DAILY group. There were no significant differences in the color, juiciness, flavor and texture of pork among treatments, with the tenderness of DAILY group being less desirable compared to that of CONT group. Moisture content of DAILY group was higher (p$lt;0.05) than that of CONT group, while lipid content was reduced in DAILY group. SR group showed the middle values between CONT and DAILY group in most criteria on growth performance and pork quality investigated. These results indicated that the recombinant pST produced by LG Chem., Ltd., Korea stimulated growth performance in growing pigs and did not show any major negative effects on pork quility, suggesting that slow release pST could be used as a growth stimulant for growing pigs.